Biosimilars naming, label transparency and authority of choice – survey findings among European physicians
Authors:
- Richard O DolinarRDRichard O Dolinar
- Michael S ReillyMRMichael S Reilly
- 15 June 2014
- journal article
- Published by Pro Pharma Communications International in Generics and Biosimilars Initiative Journal
- Vol. 3 (2) , 58-62